Scan to Download
Indian equity markets fell for the second time in the last three sessions, erasing the gains made on Tuesday.
The S&P BSE Sensex ended 4.1 percent lower at 28,265. The index had gained 3.6 percent on Tuesday. 27 out of the 30 index constituents ended the day with losses.
The NSE Nifty 50 ended 4 percent lower, erasing Tuesday's 3.8 percent surge at 8,253.80. As compared to the Sensex, the Nifty had 4 stocks that ended with gains.
All sectoral indices ended lower, led by the Nifty I.T. index, which fell 5.5 percent. The FMCG and Media index fell over 3 percent while others fell between 1-2 percent.
However, market breadth remained in favour of the advances. 937 stocks ended the day with gains while 822 posted declines.
Shares traded 4.6 percent lower at Rs 281 on the National Stock Exchange.
Shares fell as much as 7.2 percent to Rs 1,844.25 on the National Stock Exchange.
Active Stock Options
March Auto Sales Live: Ashok Leyland Drops 90%, Maruti Suzuki Falls 47%
Here is a look at how indices across Europe are faring:
The stock trades 6.9 percent lower at Rs 184.
Coronavirus India Updates: Total Covid-19 Cases Rise To 1,397, Death Toll At 35
Shares are trading 1.2 percent higher at Rs 1,616, up for the second day in a row.
Shares are trading 2.3 percent lower at Rs 42 on the National Stock Exchange.
Shares are up for the second straight day, but off the day's high at Rs 257.55, up 3.4 percent.
Shares of City Gas Distributors - IGL, MGL and Gujarat Gas too were trading with losses of over 1 percent.
Shares are off the day's high but trade 5.6 percent higher at Rs 326.35 on the National Stock Exchange.
Nifty Bank: April 1 Expiry
Shares trade 2.3 percent higher at Rs 4,375 on the National Stock Exchange, snapping a four-day losing streak.
MSCI says it defers changes to the Foreign Inclusion Factors to May review.
— BloombergQuint (@BloombergQuint) April 1, 2020
Read: https://t.co/2gmBhUlOk5 pic.twitter.com/dB2Lh6zOfR
Shares however have cooled off from their opening highs and trade 2.53 percent higher at Rs 533.45.
The closing of the U.S. FDA inspection of our Malaysia facility is an important milestone in our journey of developing Insulin Glargine for patients in the U.S. Our application for Insulin Glargine, filed by our partner Mylan is currently under review.Biocon Statement
IndusInd Ltd., Mauritius is now a debt free entity, the bank's notice to the exchanges said.
The bank also expressed concerns about the retail unsecured business. “Generally, the recovery infrastructure is set up to handle up to 5-7 percent of default rate, but in times like these, it may rise to 15 percent,” the bank said.
762 stocks have begun the trading day with gains while 613 stocks are declining.
Jim Rogers Expects ‘Worst Bear Market in My Lifetime’ in Coming Years
Find out all that you need to know going into today’s trading session here.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
